145 related articles for article (PubMed ID: 25515298)
1. Methodological and clinical aspects of alloimmunization after granulocyte transfusion in patients undergoing allogeneic stem cell transplantation.
Flaxa J; Rosner A; Hölig K; Bornhäuser M; Wassmuth R
Tissue Antigens; 2015 Feb; 85(2):93-103. PubMed ID: 25515298
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
[TBL] [Abstract][Full Text] [Related]
3. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
Seyhun Y; Ozdilli K; Oguz F; Karahan G; Onal E; Turkmen A; Eldegez U; Nane I; Çalişkan Y; Bakkaloglu H; Carin M
Transplant Proc; 2012; 44(6):1660-6. PubMed ID: 22841239
[TBL] [Abstract][Full Text] [Related]
5. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
6. Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responses.
Leith JG; Clark DA; Matthews TJ; Rosenthal KL; Luscher MA; Barber BH; MacDonald KS
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):957-65. PubMed ID: 14678602
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
8. Pre-existing anti-HLA antibodies negatively impact survival of pediatric aplastic anemia patients undergoing HSCT.
Zhu H; He J; Cai J; Yuan X; Jiang H; Luo C; Wang J; Luo C; Pan Z; Terasaki PI; Ding L; Chen J
Clin Transplant; 2014 Nov; 28(11):1225-33. PubMed ID: 25123053
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation.
Cox ST; Stephens HA; Fernando R; Karasu A; Harber M; Howie AJ; Powis S; Zou Y; Stastny P; Madrigal JA; Little AM
Hum Immunol; 2011 Oct; 72(10):827-34. PubMed ID: 21664940
[TBL] [Abstract][Full Text] [Related]
11. Pre-transplant presence of antibodies to MICA and HLA class I or II are associated with an earlier onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Lyu DM; Grazia TJ; Benson AB; Cagle LR; Freed BM; Zamora MR
Clin Transpl; 2012; ():237-46. PubMed ID: 23721028
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
[TBL] [Abstract][Full Text] [Related]
13. Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT
Br J Haematol; 2015 Jul; 170(2):247-56. PubMed ID: 25891976
[TBL] [Abstract][Full Text] [Related]
14. [Relevance of antibodies in hematopoietic stem cell transplantation: Antibodies anti-HLA, anti-platelets, anti-granulocytes, anti-erythrocytes and anti-MICA. Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Delbos F; Blouin L; Bruno B; Crocchiolo R; Desoutter J; Detrait M; Nguyen-Lejarre KT; Giannoli C; Lemarié C; Renac V; Yakoub-Agha I; Dubois V
Bull Cancer; 2020 Dec; 107(12S):S159-S169. PubMed ID: 32540096
[TBL] [Abstract][Full Text] [Related]
15. Ageing on the impact of distribution about preformed anti-HLA and anti-MICA antibody specificities in recipients prior to initial HSCT from East China.
Pan Q; Ma X; You Y; Yu Y; Fan S; Wang X; Wang M; Gao M; Gong G; Miao K; Shen J; Zhou X
Immun Ageing; 2024 Feb; 21(1):15. PubMed ID: 38378602
[TBL] [Abstract][Full Text] [Related]
16. Class I and II HLA antibodies in pediatric patients with thalassemia major.
Yee ME; Shah A; Anderson AR; Boudreaux J; Bray RA; Gebel HM; Josephson CD
Transfusion; 2016 Apr; 56(4):878-84. PubMed ID: 26666394
[TBL] [Abstract][Full Text] [Related]
17. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia.
Nakazawa Y; Saito S; Hasegawa Y; Yanagisawa R; Sakashita K; Kamijo T; Miyazaki T; Sato S; Ikeda H; Ikebuchi K; Koike K
Transfusion; 2007 Feb; 47(2):326-34. PubMed ID: 17302780
[TBL] [Abstract][Full Text] [Related]
18. Donor non-specific MICA antibodies in renal transplant recipients.
Sapák M; Chreňová S; Tirpáková J; Žilinská Z; Ďurmanová V; Shawkatová I; Jakuš V; Kuba D; Buc M
Immunobiology; 2014 Feb; 219(2):109-12. PubMed ID: 24054943
[TBL] [Abstract][Full Text] [Related]
19. Association of de novo human leukocyte antigen and major histocompatibility complex class I chain-related gene-A antibodies and proteinuria with graft survival 5 years after renal transplantation.
Zhang LW; Peng ZG; Xian WH; Cui XQ; Sun HB; Li EG; Geng LN; Zhao P; Tian J
Transplant Proc; 2013 Nov; 45(9):3249-53. PubMed ID: 24182794
[TBL] [Abstract][Full Text] [Related]
20. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
